Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 24, 2026 01:45 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 5,576 | $5.71 | $31,860.15 |
DisclosureSEC source: 0001610717-26-000058 · form4.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,856,991 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 01:45 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 40,401 | $5.87 | $236,951.87 |
DisclosureSEC source: 0001610717-26-000058 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,862,567 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:27 UTC |
Foster Eric DuaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 206,915 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000023 · form4.xml · derivative · entry 2 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,915 Underlying: Common Stock · 206,915 shares Expires 2036-01-23 F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:27 UTC |
Foster Eric DuaneChief Commercial Officer
|
GrantCommon Stock | 137,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000023 · form4.xml · nonDerivative · entry 1 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,409 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Includes the purchase of 2,780 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:23 UTC |
Williams Laura AChief Patient Officer
|
GrantStock Option (Right to Buy) · Derivative | 124,040 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000020 · form4.xml · derivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,040 Underlying: Common Stock · 124,040 shares Expires 2036-01-23 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:23 UTC |
Williams Laura AChief Patient Officer
|
GrantCommon Stock | 82,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000020 · form4.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,258 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:29 UTC |
Kelliher MikeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 154,625 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000025 · form4.xml · derivative · entry 2 Kelliher Mike · CIK 0001987188 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,625 Underlying: Common Stock · 154,625 shares Expires 2036-01-23 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:29 UTC |
Kelliher MikeSee Remarks
|
GrantCommon Stock | 103,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000025 · form4.xml · nonDerivative · entry 1 Kelliher Mike · CIK 0001987188 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,261 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:27 UTC |
Hohenleitner SusanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 128,505 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000024 · form4.xml · derivative · entry 2 Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,505 Underlying: Common Stock · 128,505 shares Expires 2036-01-23 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:27 UTC |
Hohenleitner SusanChief Financial Officer
|
GrantCommon Stock | 85,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000024 · form4.xml · nonDerivative · entry 1 Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,566 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:26 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 669,330 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000022 · form4.xml · derivative · entry 4 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669,330 Underlying: Common Stock · 669,330 shares Expires 2036-01-23 F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:26 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantCommon Stock | 446,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000022 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,902,968 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Includes the purchase of 1,385 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:25 UTC |
Brady James ParkerChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 149,185 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000021 · form4.xml · derivative · entry 2 Brady James Parker · CIK 0002088887 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,185 Underlying: Common Stock · 149,185 shares Expires 2036-01-23 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:25 UTC |
Brady James ParkerChief Human Resources Officer
|
GrantCommon Stock | 99,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000021 · form4.xml · nonDerivative · entry 1 Brady James Parker · CIK 0002088887 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,455 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:22 UTC |
Bishop John ESee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 186,500 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000019 · form4.xml · derivative · entry 2 Bishop John E · CIK 0001308911 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,500 Underlying: Common Stock · 186,500 shares Expires 2036-01-23 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 21:22 UTC |
Bishop John ESee Remarks
|
GrantCommon Stock | 124,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000019 · form4.xml · nonDerivative · entry 1 Bishop John E · CIK 0001308911 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,330 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:13 UTC |
Reilly Joseph JamesSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 69,360 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001610717-26-000028 · form4.xml · derivative · entry 2 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,360 Underlying: Common Stock · 69,360 shares Expires 2036-01-23 F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:13 UTC |
Reilly Joseph JamesSee Remarks
|
GrantCommon Stock | 46,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000028 · form4.xml · nonDerivative · entry 1 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,781 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 23:59 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 0 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · derivative · entry 3 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 23:59 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 50,000 | $6.98 | $348,900.00 |
DisclosureSEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · nonDerivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 361,563 F1 · price: This transaction was executed in multiple trades in prices ranging from $6.97 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan in August 2025. Read SEC document |
| January 08, 2026 Filed Jan 9, 2026 23:59 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionCommon Stock | 50,000 | $0.99 | $49,500.00 |
DisclosureSEC source: 0001869194-26-000002 · wk-form4_1768003182.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:21 UTC |
Reilly Joseph JamesSee Remarks
|
SaleCommon Stock | 11,086 | $5.54 | $61,382.07 |
DisclosureSEC source: 0001610717-25-000387 · form4.xml · nonDerivative · entry 1 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,914 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:22 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 5,814 | $5.54 | $32,191.54 |
DisclosureSEC source: 0001610717-25-000388 · form4.xml · nonDerivative · entry 1 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,684 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:35 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 6,426 | $5.54 | $35,580.12 |
DisclosureSEC source: 0001610717-25-000394 · form4.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,896 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:44 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 5,995 | $5.54 | $33,193.72 |
DisclosureSEC source: 0001610717-25-000397 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,895 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:42 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 46,887 | $5.54 | $259,608.63 |
DisclosureSEC source: 0001610717-25-000396 · form4.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,455,363 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:38 UTC |
Kelliher MikeSee Remarks
|
SaleCommon Stock | 5,560 | $5.54 | $30,785.16 |
DisclosureSEC source: 0001610717-25-000395 · form4.xml · nonDerivative · entry 1 Kelliher Mike · CIK 0001987188 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,181 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:30 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · derivative · entry 4 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:30 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 30,000 | $6.12 | $183,630.00 |
DisclosureSEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 3 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 366,322 F1 · price: This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:30 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 50,000 | $6.12 | $306,050.00 |
DisclosureSEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,322 F1 · price: This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 23:30 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionCommon Stock | 50,000 | $0.99 | $49,500.00 |
DisclosureSEC source: 0001628280-25-041339 · wk-form4_1756423821.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 446,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 01:02 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 15,308 | $5.93 | $90,802.46 |
DisclosureSEC source: 0001628280-25-041130 · wk-form4_1756170140.xml · nonDerivative · entry 1 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,498 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 01:13 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 6,261 | $5.93 | $37,138.37 |
DisclosureSEC source: 0001628280-25-041139 · wk-form4_1756170821.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,322 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 21:12 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 7,037 | $5.93 | $41,741.37 |
DisclosureSEC source: 0001628280-25-041137 · wk-form4_1756170732.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,052 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 01:08 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 45,687 | $5.93 | $271,001.58 |
DisclosureSEC source: 0001628280-25-041135 · wk-form4_1756170491.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,502,250 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 01:03 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 5,841 | $5.93 | $34,647.06 |
DisclosureSEC source: 0001628280-25-041131 · wk-form4_1756170178.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,890 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 28, 2025 23:29 UTC |
Kelliher MikeChief Business Officer
|
SaleCommon Stock | 5,417 | $5.93 | $32,132.02 |
DisclosureSEC source: 0001628280-25-041338 · wk-form4_1756423788.xml · nonDerivative · entry 1 Kelliher Mike · CIK 0001987188 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,741 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:40 UTC |
Cadoret-Manier OnaizaDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,059 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001628280-25-032726 · wk-form4_1750725593.xml · derivative · entry 2 Cadoret-Manier Onaiza · CIK 0001799355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,059 Underlying: Common Stock · 54,059 shares Expires 2035-06-18 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:40 UTC |
Cadoret-Manier OnaizaDirector
|
GrantCommon Stock | 41,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032726 · wk-form4_1750725593.xml · nonDerivative · entry 1 Cadoret-Manier Onaiza · CIK 0001799355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,701 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:44 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,059 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001628280-25-032730 · wk-form4_1750725839.xml · derivative · entry 2 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,059 Underlying: Common Stock · 54,059 shares Expires 2035-06-18 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:44 UTC |
Bazemore Robert BDirector
|
GrantCommon Stock | 41,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032730 · wk-form4_1750725839.xml · nonDerivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,551 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:42 UTC |
Rodgers Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,059 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · derivative · entry 3 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,059 Underlying: Common Stock · 54,059 shares Expires 2035-06-18 F3 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F4 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:42 UTC |
Rodgers Richard JDirector
|
GrantCommon Stock | 41,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · nonDerivative · entry 2 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,543 F2 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:42 UTC |
Rodgers Richard JDirector
|
GrantCommon Stock | 21,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032729 · wk-form4_1750725716.xml · nonDerivative · entry 1 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,992 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:41 UTC |
Parsey MerdadDirector
|
GrantCommon Stock | 15,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032728 · wk-form4_1750725671.xml · nonDerivative · entry 1 Parsey Merdad · CIK 0001792150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,291 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:40 UTC |
MOTT DAVID MDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,059 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · derivative · entry 3 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,059 Underlying: Common Stock · 54,059 shares Expires 2035-06-18 F4 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F5 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:40 UTC |
MOTT DAVID MDirector
|
GrantCommon Stock | 41,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · nonDerivative · entry 2 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,969,585 F3 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:40 UTC |
MOTT DAVID MDirector
|
GrantCommon Stock | 31,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032727 · wk-form4_1750725635.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,928,034 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:39 UTC |
Bhanji MunaDirector
|
GrantStock Option (Right to Buy) · Derivative | 54,059 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001628280-25-032725 · wk-form4_1750725535.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,059 Underlying: Common Stock · 54,059 shares Expires 2035-06-18 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 24, 2025 00:39 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 41,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-032725 · wk-form4_1750725535.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,353 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.